Chargement en cours...
Management of Immunosuppression in Kidney Transplant Recipients Who Develop Malignancy
The risk of cancer increases after transplantation. However, the consensus on immunosuppression (IS) adjustment after diagnosis of malignancy is lacking. Our study aims to assess the impact of IS adjustment on mortality of post-kidney transplant patients and allograft outcomes. We retrospectively re...
Enregistré dans:
| Publié dans: | J Clin Med |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6947374/ https://ncbi.nlm.nih.gov/pubmed/31835895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8122189 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|